SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-18-001671
Filing Date
2018-08-02
Accepted
2018-08-02 08:15:27
Documents
2
Period of Report
2018-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. 8-K a51846779.htm 8-K 16101
2 EXHIBIT 99.1 a51846779ex99_1.htm EX-99.1 150892
  Complete submission text file 0001157523-18-001671.txt   168158
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 18986760
SIC: 2834 Pharmaceutical Preparations